BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 23117943)

  • 1. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.
    Peltier AC; Donofrio PD
    Semin Neurol; 2012 Jul; 32(3):187-95. PubMed ID: 23117943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
    Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach.
    Stino AM; Naddaf E; Dyck PJ; Dyck PJB
    Muscle Nerve; 2021 Feb; 63(2):157-169. PubMed ID: 32914902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammatory demyelinating polyneuropathy.
    Köller H; Kieseier BC; Jander S; Hartung HP
    N Engl J Med; 2005 Mar; 352(13):1343-56. PubMed ID: 15800230
    [No Abstract]   [Full Text] [Related]  

  • 5. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
    Joint Task Force of the EFNS and the PNS
    J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.
    Saperstein DS; Barohn RJ
    Curr Neurol Neurosci Rep; 2003 Jan; 3(1):57-63. PubMed ID: 12507413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the diagnosis, pathogenesis and treatment of CIDP.
    Dalakas MC;
    Nat Rev Neurol; 2011 Aug; 7(9):507-17. PubMed ID: 21844897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health.
    Ryan M; Ryan SJ
    Am J Manag Care; 2018 Sep; 24(17 Suppl):S371-S379. PubMed ID: 30312032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic inflammatory demyelinating polyneuropathy: Diagnosis and therapeutic update].
    Franques J
    Rev Med Interne; 2019 Dec; 40(12):808-815. PubMed ID: 31677862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
    Kazmi MA; Mahdi-Rogers M; Sanvito L
    Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021].
    Kuwabara S
    Rinsho Shinkeigaku; 2024 May; 64(5):321-325. PubMed ID: 38644208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
    Kaplan A; Brannagan TH
    Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Bunschoten C; Jacobs BC; Van den Bergh PYK; Cornblath DR; van Doorn PA
    Lancet Neurol; 2019 Aug; 18(8):784-794. PubMed ID: 31076244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Hughes R
    J Clin Immunol; 2010 May; 30 Suppl 1():S70-3. PubMed ID: 20393791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
    Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
    J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP): Treatment and prognosis].
    Fukushima K; Ikeda SI
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():414-8. PubMed ID: 26480734
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
    Hughes RA
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
    Uzenot D; Azulay JP; Pouget J
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Kissel JT
    Semin Neurol; 2003 Jun; 23(2):169-80. PubMed ID: 12894382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.